VivaSight Left-sided Double Lumen Tube Study
A Comparison of Placement With the VivaSight Left-sided Double Lumen Tube With an Integrated Monitor/Camera Versus the Standard Left-sided Double Lumen Tube (DLT) With Fiberoptic Bronchoscopy in Patients Requiring One-lung Ventilation (OLV)
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The VivaSight™-DLT is a new OLV (one lung ventilation) device that contains an embedded camera. Therefore, a potential advantage is the continuous assessment of DLT position through continuous monitoring of the camera. The embedded camera of VivaSight™-DLT is positioned at the tracheal opening of the double lumen tube. It allows for continuous monitoring of the carina and bronchial tube placement. The purpose of this study is to determine if a double lumen tube (DLT) with an embedded video camera, the VivaSight DLT, can be used in similar fashion to the standard double lumen tube with fiberoptic bronchoscopy. More specifically, the investigators would like to know the difference in time to optimal position in the left bronchus between the VivaSight DLT and the standard DLT with fiberoptic bronchoscopy. In addition, the investigators would like to know if the embedded camera on the VivaSight DLT provides a view that will allow for the optimum position of the DLT in the left bronchus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2013
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2014
CompletedFirst Submitted
Initial submission to the registry
September 4, 2018
CompletedFirst Posted
Study publicly available on registry
September 11, 2018
CompletedSeptember 11, 2018
September 1, 2018
8 months
September 4, 2018
September 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intubation time
We will compare the intubation time for the VivaSight double-lumen tube (DLT) with the intubation time for standard DLT.
Within 5 minutes
Secondary Outcomes (1)
Picture reliability of the embedded camera of VivaSight double-lumen tube
Within 10 hours
Study Arms (2)
VivaSight DLT group
ACTIVE COMPARATORThoracic surgery patient is intubated with VivaSight double-lumen tube (intubation with VivaSight double-lumen tube). The intubation time, duration between the passage of the tube through the vocal cords and the confirmation of proper tube positioning by the embedded camera, is recorded. The tube position is reconfirmed by fiberoptic bronchoscopy.
Standard DLT group
PLACEBO COMPARATORThoracic surgery patient is intubated with standard double-lumen tube (intubation with standard double-lumen tube). The intubation time, duration between the passage of the tube through the vocal cords and the confirmation of proper tube positioning by fiberoptic bronchoscopy, is recorded.
Interventions
Eligibility Criteria
You may qualify if:
- At least 18 years of age
- Adult patient undergoing scheduled thoracic surgery which requires double-lumen tube placement
You may not qualify if:
- More than 90 years of age
- Patients with emergency surgery
- Prisoners
- Patient who cannot provide their own consent
- Patient refusal
- Non-English speaking patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Javier H Camposlead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Javier H Campos, MD
University of Iowa Hospitals & Clinics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 4, 2018
First Posted
September 11, 2018
Study Start
July 10, 2013
Primary Completion
March 21, 2014
Study Completion
March 21, 2014
Last Updated
September 11, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- IPD will be available for sharing immediately after publication and ending 5 years following article publication.
- Access Criteria
- IPD will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.
All of the individual participant data collected during the trial, after deidentification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. IPD will be available for sharing immediately after publication and ending 5 years following article publication.